CRS
Overvalued by 77% based on the discounted cash flow analysis.
Market cap | $12.01 Billion |
---|---|
Enterprise Value | $12.39 Billion |
Dividend Yield | $0.80 (0.33%) |
Earnings per Share | $7.49 |
Beta | 1.45 |
Outstanding Shares | 50,100,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 32.1 |
---|---|
PEG | 165.98 |
Price to Sales | 4.22 |
Price to Book Ratio | 6.49 |
Enterprise Value to Revenue | 4.31 |
Enterprise Value to EBIT | 23.83 |
Enterprise Value to Net Income | 32 |
Total Debt to Enterprise | 0.06 |
Debt to Equity | 0.37 |
No data
No data